[1] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].北京:人民卫生出版社,2011:395.
[2] 李百玲,柴家科,胡泉,等.外源性肺泡表面活性物质对重度烧冲复合伤大鼠急性肺损伤的治疗作用[J].中华医学杂志,2015,95(2):133.
[3] LAMBERTSEN KL,STERGAARD K,CLAUSEN BH, et al.No effect of ablation of surfactant protein-D on acute cerebral infarction in mice[J].J Neuroinflammation,2014,19(11):123.
[4] 傅建平,胡安辉,袁水生,等.早期应用持续气道正压呼吸和肺泡表面活性物质防治新生儿呼吸窘迫综合征的探讨[J].江西医药,2013,48(6):518.
[5] 王立,吴越,杜萍,等.肺表面活性物质对兔胸部撞击肺损伤中促炎性细胞因子的影响[J].中国医药导报,2015,12(10):14.
[6] KUMAR R,JAMBHEKAR NA,MARCHEVSKY AM, et al.Toward an evidence-based proposal for the best minimal immunohistochemical panel to infer lung carcinoma in metastatic supraclavicular lymph node[J].Ann Diagn Pathol,2014,18(2):53.
[7]
[8] 夏宁,叶巍岭,杨代秀,等.肺表面活性物质治疗新生儿肺内/肺外源性急性肺损伤研究[J].中国新生儿科杂志,2014,29(2):90.
[9] SILVA PL,MORAES L,SANTOS RS, et al.Recruitment maneuvers modulate epithelial and endothelial cell response according to acute lung injury etiology[J].Crit Care Med,2013,41(10):256.
[10] 王立,张裕祥,杜萍,等.不同肺表面活性物质对兔胸部撞击肺损伤中促炎性细胞因子的影响[J].广西医学,2015,37(3):302.
[11] 经俊,李元海.肺表面活性物质相关蛋白A在体外循环后肺损伤中作用的研究进展[J].国际麻醉学与复苏杂志,2015,36(2):161.
[12] GORTNER L,TUTDIBI E.Respiratory disorders in preterm and term neonates:an update on diagnostics and therapy[J].Z Geburtshilfe Neonatol,2011,215(4):145.
[13] 上官华英,魏刚,傅碧云,等.经气管导管改良法推注肺表面活性物质治疗新生儿呼吸窘迫综合征临床应用[J].江西医药,2014,10(4):1065.
[14] 阎志新,张西凯,张有起,等.改良法推注肺表面活性物质神经系统后遗症观察[J].中国误诊学杂志,2012,12(9):2039.
[15] DE LUCA D,MINUCCI A,TRIPODI D, et al.Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates[J].Intensive Care Med,2011,37(7):1158.
[16] 封成芳,陈宏琼,廖沛光.肺表面活性物质联合经鼻持续正压通气治疗新生儿肺透明膜病临床效果分析[J].内科,2014,2(13):167.
[17] 郑小瑜,郑兴惠.改良法注入肺表面活性物质治疗早产儿呼吸窘迫综合征临床观察[J].中国新生儿科杂志,2015,30(2):127.